VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 30 filers reported holding VASCULAR BIOGENICS LTD in Q3 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $18 | +200.0% | 79,892 | +113.5% | 0.00% | 0.0% |
Q1 2023 | $6 | 0.0% | 37,424 | -27.9% | 0.00% | 0.0% |
Q4 2022 | $6 | -100.0% | 51,915 | -43.6% | 0.00% | 0.0% |
Q3 2022 | $14,000 | -46.2% | 92,085 | +475.1% | 0.00% | -50.0% |
Q2 2022 | $26,000 | +8.3% | 16,013 | +29.8% | 0.00% | 0.0% |
Q4 2021 | $24,000 | -22.6% | 12,341 | -19.3% | 0.00% | -33.3% |
Q3 2021 | $31,000 | -67.4% | 15,298 | -61.4% | 0.00% | -66.7% |
Q2 2021 | $95,000 | +41.8% | 39,618 | -28.2% | 0.01% | -18.2% |
Q3 2020 | $67,000 | +168.0% | 55,166 | +184.4% | 0.01% | +266.7% |
Q2 2020 | $25,000 | +25.0% | 19,400 | +57.4% | 0.00% | +200.0% |
Q3 2018 | $20,000 | -85.8% | 12,323 | -80.8% | 0.00% | -83.3% |
Q2 2018 | $141,000 | -10.2% | 64,203 | -5.9% | 0.01% | -25.0% |
Q1 2018 | $157,000 | – | 68,222 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Telemetry Investments, L.L.C. | 152,764 | $365,000 | 0.50% |
Ikarian Capital, LLC | 800,811 | $1,915,000 | 0.16% |
DAFNA Capital Management LLC | 306,980 | $734,000 | 0.15% |
PVG ASSET MANAGEMENT CORP | 12,155 | $29,050,000 | 0.09% |
Phoenix Holdings Ltd. | 1,060,300 | $2,534,000 | 0.05% |
Virtu Financial LLC | 39,618 | $95,000 | 0.01% |
BOOTHBAY FUND MANAGEMENT, LLC | 89,689 | $214,000 | 0.01% |
HBK Sorce Advisory LLC | 22,000 | $53,000 | 0.00% |
MORGAN STANLEY | 693,420 | $1,658,000 | 0.00% |
Bank of New York Mellon Corp | 25,000 | $60,000 | 0.00% |